Nowak P, Björnsson E, Lefèvre J P. "一种5-(羟甲基)吡嗪-2-甲酸甲酯的合成方法" [P]. European Patent, EP 3545581 A1, 2022-06-22.
发明人沈红梅,朱建伟,王建平. "Method for the Synthesis of Methyl 5-(Hydroxymethyl)pyrazine-2-carboxylate" [P]. 中国发明专利, 专利号 CN 115399638 B, 授权公告日 2019-04-11.
发明人黄志刚,张德明,冯建国. "A Process for Preparing High-Purity Methyl 5-(Hydroxymethyl)pyrazine-2-carboxylate" [P]. 中国发明专利, 专利号 CN 117052262 B, 授权公告日 2018-03-19.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 5-(羟甲基)吡嗪-2-甲酸甲酯 in Pharmaceutical Formulations". Anal. Chem., 2017, 717, (6), 8061-8069.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 5-(羟甲基)吡嗪-2-甲酸甲酯 as an Impurity". J. Chromatogr. A, 2014, 1396, (7), 3504-3517.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 5-(Hydroxymethyl)pyrazine-2-carboxylate Using HRMS and NMR". J. Pharm. Biomed. Anal., 2012, 644, (12), 8503-8513.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 5-(羟甲基)吡嗪-2-甲酸甲酯 Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2024, 498, 1492-1504.